Karl Schmieder

VIEW GENIE

For more than 20 years, Karl Schmieder advised leading life sciences companies on how to tell their story to the multiple audiences they need to engage. From two-man start-ups to Fortune 10 pharma companies, Karl has helped companies make the transition from mass-marketing to personalized digital engagement strategies. Synthetic biology – the next iteration of biotech – is applying the principles of engineering to biotechnology, making it more accessible and impacting all levels of business. A sought-after speaker and writer, Karl lectures regularly at NYU and teaches businesses how to to prepare for the age of engineered biology. He teaches thought leadership strategies to compani…
Cancel